Skip to content
Peptide research

Oxytocin

Also known as Pitocin
Category
Hormone & Sexual Health
Administration routes
InjectableNasal
Regulatory status
FDA-approved

What it is

A natural 9-amino-acid hormone, currently FDA-approved as an injection for obstetric uses including labor induction and postpartum bleeding control, now sold off-label for muscle, metabolic, and mood benefits. Human evidence is solid for obstetric use and modest for social effects, but the anti-aging claims rest mostly on animal data, with lifespan extension speculative. The main danger is prolonged IV use, risking severe water intoxication and uterine hyperstimulation. Longevity and intranasal uses are not FDA-approved.

Read Full record

Studied uses & evidence

Studied uses(7)

  • Muscle regeneration and anti-sarcopenia effects

    Medium

    Strong mouse regeneration data plus one small human pilot trial showing modest lean-mass gains.

  • Reversal of epigenetic aging and neuroinflammation

    Low

    Preliminary and animal-only, showing DNA demethylation and reduced neuroinflammation in aged mouse brain.

  • Lifespan extension (in combination with ALK5 inhibitor)

    Speculative

    Rests on a single 2025 mouse study, extending life in males only, not yet replicated.

Evidence limits

Evidence Level
Level 1 — FDA Approved

Oxytocin has the strongest clinical evidence base of any peptide being studied for longevity. For its FDA-approved obstetric indications, decades of Level I evidence support its safety and efficacy. For aging-relevant applications, key human evidence includes: (1) a pilot RCT in 21 older adults showing significant lean mass gains and LDL reduction with intranasal oxytocin (Espinoza et al. 2021); (2) a safety/tolerability RCT in 95 older men showing 4-week chronic intranasal dosing is safe with no significant adverse events (Rung et al. 2021); (3) multiple RCTs for autism/social cognition (mixed results but strong safety data across hundreds of participants); and (4) robust preclinical evidence including muscle regeneration, epigenetic reversal, bone formation, and lifespan extension. The major gap is the absence of large, multi-center Phase 2/3 RCTs specifically targeting aging outcomes in older adults.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

Do not use if

  • Abnormal fetal position (non-obstetric)

    Absolute

    FDA contraindication for obstetric use when vaginal delivery is not appropriate.

  • Placenta previa or vasa previa

    Absolute

    Uterine contractions from oxytocin could cause fatal hemorrhage.

  • Hypertonic uterine patterns

    Absolute

    FDA contraindication — can cause uterine rupture.

  • Hyponatremia risk (high dose/prolonged use)

    High

    Oxytocin has antidiuretic properties. Prolonged or high-dose use can cause water intoxication and hyponatremic encephalopathy.

  • Uncontrolled hypertension or severe cardiac arrhythmias

    High

    Oxytocin causes vasodilation and reflex tachycardia. Use caution with hemodynamic instability.

Risk summary(6)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Severe water intoxication with convulsions/coma with prolonged IV use

    High
  • IV bolus can cause transient QTc prolongation and tachycardia

    Moderate
  • Headache is the most common adverse effect with intranasal oxytocin

    Low
  • Nausea and vomiting (mainly obstetric IV use)

    Low
  • Uterine hyperstimulation in labor induction

    High
  • Chronic high doses may paradoxically desensitize/increase aggression

    Theoretical
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.